Primary sclerosing cholangitis: diagnostic and management challenges
- PMID: 29138587
- PMCID: PMC5680897
- DOI: 10.2147/CEG.S105872
Primary sclerosing cholangitis: diagnostic and management challenges
Abstract
Primary sclerosing cholangitis (PSC) is a chronic immune-mediated disease affecting intra- and extrahepatic bile ducts, primarily the large biliary ducts. Clinical manifestations are broad, and the spectrum encompasses asymptomatic cholestasis, icteric cholangitis with pruritis, cirrhosis, and cholangiocarcinoma. Though rare, PSC has a propensity to affect young to middle-aged males and is strongly associated with inflammatory bowel disease. There is an unmet need for effective medical treatments for PSC, and to date, the only curative therapy is liver transplantation reserved for those with end-stage liver disease. This article addresses the diagnostic and management challenges of PSC, with a succinct analysis of existing therapies, their limitations, and a glimpse into the future of the management of this multifaceted pathologic entity.
Keywords: PSC; management; primary sclerosing cholangitis.
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
References
-
- Chapman R, Fevery J, Kalloo A, et al. Diagnosis and management of primary sclerosing cholangitis. Hepatology. 2009;51(2):660–678. - PubMed
-
- Lindor K, Kowdley K, Harrison M. ACG clinical guideline: primary sclerosing cholangitis. Am J Gastroenterol. 2015;110(5):646–659. - PubMed
-
- Lee Y, Kaplan M. Primary sclerosing cholangitis. N Engl J Med. 1995;332(14):924–933. - PubMed
-
- Angulo P, Lindor K. Primary sclerosing cholangitis. Hepatology. 1999;30(1):325–332. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
